Experienced in Adenosine Deaminase 2 Deficiency

Dr. James P. Zidar

Interventional Cardiology | Cardiology
Rex Hospital Inc
2800 Blue Ridge Rd, Suite 400, 
Raleigh, NC 
Accepting New Patients
Experienced in Adenosine Deaminase 2 Deficiency
Rex Hospital Inc
2800 Blue Ridge Rd, Suite 400, 
Raleigh, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Zidar is an Interventional Cardiologist and a Cardiologist in Raleigh, North Carolina. Dr. Zidar is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Carotid Artery Disease, Angina, Arterial Insufficiency, Percutaneous Coronary Intervention (PCI), and Pacemaker Implantation. Dr. Zidar is currently accepting new patients.

His clinical research consists of co-authoring 22 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in NC
Hospital Affiliations
Rex Hospital
Sampson Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
MVP Health
  • EPO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

REX HOSPITAL INC
2800 Blue Ridge Rd, Suite 400, Raleigh, NC 27607

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent - the PERFORMANCE II Study
Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent - the PERFORMANCE II Study
Enrollment Status: Active_not_recruiting
Publish Date: June 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Enrollment Status: Completed
Publish Date: December 20, 2023
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Enrollment Status: Completed
Publish Date: October 11, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects With Hypertension
A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects With Hypertension
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2023
Intervention Type: Drug, Device
Study Drug: Dehydrated alcohol
Study Phase: Phase 3
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Device
Study Phase: Not Applicable
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)
Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)
Enrollment Status: Unknown
Publish Date: February 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

21 Total Publications

Radial Approach Renal Denervation: A First-in-Man Case With the 4-F TIVUS Catheter.
Radial Approach Renal Denervation: A First-in-Man Case With the 4-F TIVUS Catheter.
Journal: JACC. Case reports
Published: March 03, 2025
Similar Doctors
Advanced in Adenosine Deaminase 2 Deficiency
Dr. Patrick J. Simpson
Interventional Cardiology | Cardiology
Advanced in Adenosine Deaminase 2 Deficiency
Dr. Patrick J. Simpson
Interventional Cardiology | Cardiology

Pinehurst Medical Clinic Inc

15 Regional Dr, 
Pinehurst, NC 
 (59.6 miles away)
910-295-5511
Languages Spoken:
English, German, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

Patrick Simpson is an Interventional Cardiologist and a Cardiologist in Pinehurst, North Carolina. Dr. Simpson is rated as a Distinguished provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, and Arterial Embolism. Dr. Simpson is currently accepting new patients.

Advanced in Adenosine Deaminase 2 Deficiency
Dr. Richard J. Pacca
Cardiology | Nuclear Medicine
Advanced in Adenosine Deaminase 2 Deficiency
Dr. Richard J. Pacca
Cardiology | Nuclear Medicine

Granville Health Inc

1010 College St, 
Oxford, NC 
 (35.5 miles away)
Languages Spoken:
English, Sign Language, Spanish
See accepted insurances
Accepting New Patients

Richard Pacca is a Cardiologist and a Nuclear Medicine provider in Oxford, North Carolina. Dr. Pacca is rated as a Distinguished provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, and Endocarditis. Dr. Pacca is currently accepting new patients.

Advanced in Adenosine Deaminase 2 Deficiency
Dr. Krishna C. Alluri
Cardiology
Advanced in Adenosine Deaminase 2 Deficiency
Dr. Krishna C. Alluri
Cardiology

Duke Health Integrated Practice Inc

1234 Huffman Mill Rd, 
Burlington, NC 
 (47.7 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Krishna Alluri is a Cardiologist in Burlington, North Carolina. Dr. Alluri is rated as a Distinguished provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Heart Attack, Apoplexy, Necrosis, Arterial Embolism, and Pacemaker Implantation. Dr. Alluri is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zidar's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile